Cargando…

Detection of Quebec Polyomavirus DNA in Samples from Different Patient Groups

Polyomaviruses infect many species, including humans. So far, 15 polyomaviruses have been described in humans, but it remains to be established whether all of these are genuine human polyomaviruses. The most recent polyomavirus to be detected in a person is Quebec polyomavirus (QPyV), which was iden...

Descripción completa

Detalles Bibliográficos
Autores principales: Prezioso, Carla, Van Ghelue, Marijke, Pietropaolo, Valeria, Moens, Ugo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8158138/
https://www.ncbi.nlm.nih.gov/pubmed/34070030
http://dx.doi.org/10.3390/microorganisms9051082
_version_ 1783699821263060992
author Prezioso, Carla
Van Ghelue, Marijke
Pietropaolo, Valeria
Moens, Ugo
author_facet Prezioso, Carla
Van Ghelue, Marijke
Pietropaolo, Valeria
Moens, Ugo
author_sort Prezioso, Carla
collection PubMed
description Polyomaviruses infect many species, including humans. So far, 15 polyomaviruses have been described in humans, but it remains to be established whether all of these are genuine human polyomaviruses. The most recent polyomavirus to be detected in a person is Quebec polyomavirus (QPyV), which was identified in a metagenomic analysis of a stool sample from an 85-year-old hospitalized man. We used PCR to investigate the presence of QPyV DNA in urine samples from systemic lupus erythematosus (SLE) patients (67 patients; 135 samples), multiple sclerosis patients (n = 35), HIV-positive patients (n = 66) and pregnant women (n = 65). Moreover, cerebrospinal fluid from patients with suspected neurological diseases (n = 63), nasopharyngeal aspirates from patients (n = 80) with respiratory symptoms and plasma samples from HIV-positive patients (n = 65) were examined. QPyV DNA was found in urine from 11 (16.4%), 10 (15.4%) and 5 (14.3%) SLE patients, pregnant women, and multiple sclerosis patients, respectively. No QPyV DNA could be detected in the other samples. Alignment with the only available QPyV sequence in the GenBank revealed amino acid substitutions in the HI-loop of capsid protein VP1 in 6/28 of the isolates. Our results show that QPyV viruria can occur, but whether it may cause clinical symptoms in the patients remains to be determined.
format Online
Article
Text
id pubmed-8158138
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-81581382021-05-28 Detection of Quebec Polyomavirus DNA in Samples from Different Patient Groups Prezioso, Carla Van Ghelue, Marijke Pietropaolo, Valeria Moens, Ugo Microorganisms Communication Polyomaviruses infect many species, including humans. So far, 15 polyomaviruses have been described in humans, but it remains to be established whether all of these are genuine human polyomaviruses. The most recent polyomavirus to be detected in a person is Quebec polyomavirus (QPyV), which was identified in a metagenomic analysis of a stool sample from an 85-year-old hospitalized man. We used PCR to investigate the presence of QPyV DNA in urine samples from systemic lupus erythematosus (SLE) patients (67 patients; 135 samples), multiple sclerosis patients (n = 35), HIV-positive patients (n = 66) and pregnant women (n = 65). Moreover, cerebrospinal fluid from patients with suspected neurological diseases (n = 63), nasopharyngeal aspirates from patients (n = 80) with respiratory symptoms and plasma samples from HIV-positive patients (n = 65) were examined. QPyV DNA was found in urine from 11 (16.4%), 10 (15.4%) and 5 (14.3%) SLE patients, pregnant women, and multiple sclerosis patients, respectively. No QPyV DNA could be detected in the other samples. Alignment with the only available QPyV sequence in the GenBank revealed amino acid substitutions in the HI-loop of capsid protein VP1 in 6/28 of the isolates. Our results show that QPyV viruria can occur, but whether it may cause clinical symptoms in the patients remains to be determined. MDPI 2021-05-18 /pmc/articles/PMC8158138/ /pubmed/34070030 http://dx.doi.org/10.3390/microorganisms9051082 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Communication
Prezioso, Carla
Van Ghelue, Marijke
Pietropaolo, Valeria
Moens, Ugo
Detection of Quebec Polyomavirus DNA in Samples from Different Patient Groups
title Detection of Quebec Polyomavirus DNA in Samples from Different Patient Groups
title_full Detection of Quebec Polyomavirus DNA in Samples from Different Patient Groups
title_fullStr Detection of Quebec Polyomavirus DNA in Samples from Different Patient Groups
title_full_unstemmed Detection of Quebec Polyomavirus DNA in Samples from Different Patient Groups
title_short Detection of Quebec Polyomavirus DNA in Samples from Different Patient Groups
title_sort detection of quebec polyomavirus dna in samples from different patient groups
topic Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8158138/
https://www.ncbi.nlm.nih.gov/pubmed/34070030
http://dx.doi.org/10.3390/microorganisms9051082
work_keys_str_mv AT preziosocarla detectionofquebecpolyomavirusdnainsamplesfromdifferentpatientgroups
AT vangheluemarijke detectionofquebecpolyomavirusdnainsamplesfromdifferentpatientgroups
AT pietropaolovaleria detectionofquebecpolyomavirusdnainsamplesfromdifferentpatientgroups
AT moensugo detectionofquebecpolyomavirusdnainsamplesfromdifferentpatientgroups